PHASE-I CLINICAL-EVALUATION OF HUMAN-PLASMA FIBRONECTIN (FN) IN TRAUMA PATIENTS

被引：0
|
作者：
HOROWITZ, MS
HOROWITZ, B
MAY, JR
TREAT, RC
HALL, EL
DIPIRO, JT
DORAN, JE
MANSBERGER, AR
机构：
[1] MED COLL GEORGIA,AUGUSTA,GA 30912
[2] NEW YORK BLOOD CTR,NEW YORK,NY 10021
来源：
THROMBOSIS AND HAEMOSTASIS | 1985年 / 54卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 248
页数：1
相关论文
共 50 条
  • [31] TEMPERATURE (T-DEGREES) DEPENDENT CONFORMATIONAL CHANGE IN HUMAN-PLASMA FIBRONECTIN (FN) DEMONSTRATED WITH MONOCLONAL-ANTIBODIES (MAB)
    BROWN, EJ
    BOHNSACK, JF
    OSHEA, JJ
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1069 - 1069
  • [32] PHASE-I EVALUATION OF RECOMBINANT HUMAN INTERLEUKIN-6
    RITCH, PS
    SCHILLER, J
    RIVKIN, S
    KEEVER, C
    WITT, PL
    GROSSBERG, SE
    BREITMEYER, JB
    DRECHSLER, D
    TRUITT, RL
    VONHOFF, DD
    BORDEN, EC
    BLOOD, 1993, 82 (10) : A367 - A367
  • [33] PHASE-I CLINICAL-EVALUATION OF 2,3-DIHYDRO-H-1-IMIDAZO[1,2-B]PYRAZOLE
    YAP, BS
    MURPHY, WK
    BURGESS, MA
    VALDIVIESO, M
    BODEY, GP
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1849 - 1851
  • [34] GEMCITABINE IN LEUKEMIA - A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY
    GRUNEWALD, R
    KANTARJIAN, H
    DU, M
    FAUCHER, K
    TARASSOFF, P
    PLUNKETT, W
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) : 406 - 413
  • [35] THE CLINICAL-EVALUATION OF PLASMA FIBRONECTIN AS A MARKER FOR NUTRITIONAL DEPLETION AND REPLETION AND AS A MEASURE OF NITROGEN-BALANCE
    KIRBY, DF
    MARDER, RJ
    CRAIG, RM
    ESKILDSEN, R
    MIDDAUGH, P
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1985, 9 (06) : 705 - 708
  • [36] PHASE-I AND CLINICAL PHARMACOLOGIC EVALUATION OF TIAZOFURIN (TCAR) BY AN INTERMITTENT SCHEDULE
    CURRIE, VE
    BUDMAN, D
    HANCOCK, C
    LOKOS, G
    WILLIAMS, L
    BAUER, T
    PARENTE, R
    YOUNG, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 188 - 188
  • [37] PHASE-I CLINICAL-EVALUATION OF GD-EOB-DTPA AS A HEPATOBILIARY MR CONTRAST AGENT - SAFETY, PHARMACOKINETICS, AND MR-IMAGING
    HAMM, B
    STAKS, T
    MUHLER, A
    BOLLOW, M
    TAUPITZ, M
    FRENZEL, T
    WOLF, KJ
    WEINMANN, HJ
    LANGE, L
    RADIOLOGY, 1995, 195 (03) : 785 - 792
  • [38] A PHASE-I EVALUATION OF POLY(I,C)-LC IN CANCER-PATIENTS
    STEVENSON, HC
    ABRAMS, PG
    SCHOENBERGER, CS
    SMALLEY, RB
    HERBERMAN, RB
    FOON, KA
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1985, 4 (06): : 650 - 655
  • [39] COMBINATION CLINICAL-TRIALS WITH THYMIDINE AND FLUOROURACIL - A PHASE-I AND CLINICAL PHARMACOLOGIC EVALUATION
    WOODCOCK, TM
    MARTIN, DS
    DAMIN, LAM
    KEMENY, NE
    YOUNG, CW
    CANCER, 1980, 45 (05) : 1135 - 1143
  • [40] FLUID-PHASE INTERACTION BETWEEN HUMAN-PLASMA FIBRONECTIN AND GELATIN DETERMINED BY FLUORESCENCE POLARIZATION ASSAY
    FORASTIERI, H
    INGHAM, KC
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 227 (02) : 358 - 366
12345